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DNA methylation is a major epigenetic modi-
fi  cation of the genome that regulates genomic 
function during cell diff  erentiation (1–4). DNA 
methylation patterns are established during 
early embryogenesis and gametogenesis, and 
are maintained in somatic cells thereafter (5). 
The DNA methyltransferases Dnmt1, Dnmt3a, 
and Dnmt3b catalyze methylation of CpG di-
nucleotides in genomic DNA (6–8). Dnmt3a 
and Dnmt3b supposedly act as de novo methyl-
transferases, whereas Dnmt1 acts as a “mainte-
nance” methyltransferase (9).
Embryogenesis is severely impaired in Dnmt1- 
or Dnmt3b-defi  cient mice (7, 10). Spermato-
genesis is impaired in Dnmt3a-defi  cient mice 
(8). Embryonic stem (ES) cells without Dnmt3a 
and Dnmt3b are viable and maintain replication 
potential but progressively lose diff  erentiation 
potential with repeated passage (11). These data 
imply that when stem cells undergo diff  eren-
tiation, Dnmt3a and Dnmt3b progressively 
establish DNA methylation status in each cell 
lineage, and then restrict cells’ diff  erentiation 
potential. We decided to examine the function 
of Dnmt3a and Dnmt3b in hematopoietic stem 
cells (HSCs) because HSCs are the best-studied 
stem cells and an excellent model system for 
studies of cell diff  erentiation.
Because Dnmt3a-defi  cient mice die by 4 wk 
of age, and Dnmt3b-defi  cient mice die before 
birth, we conditionally disrupted Dnmt3a, 
  Dnmt3b, or both Dnmt3a and Dnmt3b in adult 
mouse HSCs. We show that Dnmt3a and 
Dnmt3b establish DNA methylation status as a 
de novo DNA methyltransferase during the mat-
uration of hematopoietic cells, and HSCs, un-
like ES cells, require either Dnmt3a or Dnmt3b 
for self-renewal, but not for   diff  erentiation into 
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DNA methylation is an epigenetic modifi  cation essential for development. The DNA methyl-
transferases Dnmt3a and Dnmt3b execute de novo DNA methylation in gastrulating 
  embryos and differentiating germline cells. It has been assumed that these enzymes gener-
ally play a role in regulating cell differentiation. To test this hypothesis, we examined the 
role of Dnmt3a and Dnmt3b in adult stem cells. CD34-/low, c-Kit+, Sca-1+, lineage marker− 
(CD34− KSL) cells, a fraction of mouse bone marrow cells highly enriched in hematopoietic 
stem cells (HSCs), expressed both Dnmt3a and Dnmt3b. Using retroviral Cre gene transduc-
tion, we conditionally disrupted Dnmt3a, Dnmt3b, or both Dnmt3a and Dnmt3b (Dnmt3a/
Dnmt3b) in CD34− KSL cells purifi  ed from mice in which the functional domains of these 
genes are fl  anked by two loxP sites. We found that Dnmt3a and Dnmt3b function as 
de novo DNA methyltransferases during differentiation of hematopoietic cells. Unexpectedly, 
in vitro colony assays and in vivo transplantation assays showed that both myeloid and 
lymphoid lineage differentiation potentials were maintained in Dnmt3a-, Dnmt3b-, and 
Dnmt3a/Dnmt3b-defi  cient HSCs. However, Dnmt3a/Dnmt3b-defi  cient HSCs, but not 
Dnmt3a- or Dnmt3b-defi  cient HSCs, were incapable of long-term reconstitution in trans-
plantation assays. These fi  ndings establish a critical role for DNA methylation by Dnmt3a 
and Dnmt3b in HSC self-renewal.
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all blood cell lineages. This work provides insights into how 
DNA methylation controls normal stem cell functions.
RESULTS AND DISCUSSION
We fi  rst examined expression of Dnmt1, Dnmt3a, Dnmt3a2 
(an isoform of Dnmt3a, predominantly expressed in undiff  er-
entiated ES cells; reference 12), Dnmt3b, and Dnmt3L (13) in 
various hematopoietic cell populations from C57BL/6 (B6) 
mice by RT-PCR analysis. As shown in Fig. 1 A, Dnmt1 was 
detected in all blood lineages. Dnmt3L, which encodes a pro-
tein lacking enzymatic activity but required for establishment 
of maternal methylation imprints (8, 13, 14), was undetect-
able in all blood lineages. Dnmt3a, Dnmt3a2, and Dnmt3b 
were expressed mainly in B and T lymphoid lineages. Inter-
estingly, expression of both Dnmt3a and Dnmt3b was readily 
detectable in CD34-/low, c-Kit+, Sca-1+, lineage marker− 
(CD34− KSL) cells, a population exclusively enriched in 
HSCs (15). Immunocytostaining with anti-Dnmt3a or -Dn-
mt3b antibodies also revealed expression of these proteins in 
CD34− KSL cells (Fig. 1 B). Both Dnmt3a and Dnmt3b 
were detected in 55.9% of the cells, and either Dnmt3a or 
Dnmt3b was detected in, respectively, 3.4 and 40.7% of the 
cells. We extended this immunostaining analysis to various 
cells in diff   erent hematopoietic lineages. Consistent with 
RT-PCR data, expression of both Dnmt3a and Dnmt3b was 
strong in B and T lymphoid lineages, but barely detectable in 
neutrophil/macrophage and erythroid lineages (not depicted). 
These and previous data (11) predicted that these enzymes 
are required for functions of HSCs and lymphoid cells.
We next examined the DNA methylation status in each 
hematopoietic lineage using immunocytochemistry (16). The 
DNA methylation level in B and T lymphoid lineage or my-
eloid lineage cells was very high or moderate, respectively. 
Cells’ DNA methylation levels correlated with their Dnmt3 
expression levels (Fig. 2 A). The DNA methylation level in 
CD34− KSL cells was unexpectedly much lower than that 
in mature hematopoietic cells (Fig. 2 A). These data were 
further confi  rmed by a modifi  ed method of methylation-
  sensitive representational diff  erence analysis using a methylation-
sensitive HpaII restriction enzyme (17). After the genomic 
DNA of CD34− KSL cells was digested by a HpaII restric-
tion enzyme, the digested DNA fragments were amplifi  ed 
by PCR and checked by electrophoresis (Fig. 2 B). These 
data suggest that the DNA methylation level of HSCs is low 
and that it gradually increases as HSC progeny mature into 
functional blood cells.
To clarify whether Dnmt3a or Dnmt3b is required 
for self-renewal and multilineage diff   erentiation of HSCs, 
we decided to analyze mice conditional for these genes 
(Dnmt3a2lox/2lox, Dnmt3b2lox/2lox, or both Dnmt3a2lox/2lox and 
Dnmt3b2lox/2lox [Dnmt3a2lox/2lox/Dnmt3b2lox/2lox] mice) by 
using the retroviral Cre gene transduction system (18, 19). 
The conditional alleles and the Cre-mediated deletion alleles 
were designated as 2lox and 1lox, respectively (8, 20). As il-
lustrated in Fig. 3 A, 500 CD34− KSL cells were isolated 
from the BM cells of each 2lox/2lox mouse and infected 
with pMSCV-Cre-IRES-enhanced GFP (Cre-EGFP) retro-
virus or pMSCV-IRES-EGFP (EGFP) retrovirus at a dose of 
120 multiplicity of infection (21, 22). After an additional 2.5 d 
of incubation with the retrovirus, the cells were divided into 
two aliquots to be examined by in vitro methylcellulose col-
ony assays and in vivo competitive repopulation assays.
Numbers of colonies formed by CD34− KSL cells from 
Dnmt3a2lox/2lox or Dnmt3b2lox/2lox mice did not diff  er  sig-
nifi  cantly, regardless of whether these cells were infected 
with Cre-EGFP or EGFP retrovirus (Fig. 3 B). To evaluate 
the presence of myeloid lineage cells in each colony, cells 
composing colonies were morphologically identifi  ed as neu-
trophils (n), macrophages (m), erythroblasts (E), and mega-
karyocytes (M). As shown in Fig. 3 C, Dnmt3a2lox/2lox and 
Dnmt3b2lox/2lox cells formed a variety of colony types after 
infection with Cre-EGFP or EGFP retrovirus. 51.6 ± 17.3% 
or 31.4 ± 5.8% of Dnmt3a2lox/2lox cells infected with EGFP 
or Cre-EGFP retrovirus exhibited EGFP fl  uorescence. 45.6 ± 
10.6% or 26.4 ± 12.4% of Dnmt3b2lox/2lox cells infected with 
EGFP or Cre-EGFP retrovirus exhibited EGFP fl  uores-
cence (Fig. 3 D).
To verify deletion of the target genes in EGFP+ colo-
nies, PCR was performed on genomic DNA extracted 
from colonies formed by Dnmt3a2lox/2lox or Dnmt3b2lox/2lox 
cells infected with Cre-EGFP retrovirus (Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20060750/DC1). 
Figure 1.  Expression of Dnmt3a and Dnmt3b in hematopoietic 
cells. (A) Expression of Dnmt1, Dnmt3a, Dnmt3a2, Dnmt3b, Dnmt3L, and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was examined by 
semiquantitative RT-PCR analysis. cDNAs were prepared from CD34− KSL 
cells, CD34+ KSL cells, lineage marker− cells, Gr-1+ Mac-1+ neutrophils/
macrophages, TER119+ erythroblasts, and B220+ B lymphoid cells in the 
BM; from B220+ B lymphoid cells, Thy-1.2+ T lymphoid cells, and Nk-1.1+ 
NK/NKT cells in the spleen; and from CD4−CD8−, CD4+CD8+, CD4+CD8−, 
and CD4−CD8+ T lymphoid cells in the thymus of adult B6 mice. (B) Immuno-
staining detected Dnmt3a (red) and Dnmt3b (green) in the cytoplasm and 
nucleus (blue) of CD34− KSL cells. Bars, 4 μm.JEM VOL. 204, April 16, 2007  717
BRIEF DEFINITIVE REPORT
Each gene turned out to be deleted from all EGFP+ colo-
nies examined (Tables S1 and S2). Among these EGFP+ and 
gene-deleted colonies, nmEM colonies were detected (Fig. 
3 C). From these results, we concluded that the lack of Dn-
mt3a or Dnmt3b has little eff  ect on in vitro myeloid colony 
formation by HSCs and their immediate progeny.
We then examined repopulating activity in Dnmt3a2lox/2lox 
or Dnmt3b2lox/2lox CD34− KSL cells after infection with Cre-
EGFP or EGFP retrovirus. To do this, 0.1 vol of infected 
cultured cells (equivalent to 50 culture-initiating CD34− KSL 
cells) from the 2lox/2lox mice (Ly5.2) was transplanted into 
a lethally irradiated B6-Ly5.1 mouse together with 2 × 105 
competitor cells from a B6-Ly5.1/Ly5.2 F1 mouse. Recipi-
ent mice were analyzed 4 and 16 wk after transplantation. As 
shown in Fig. 3 D, regardless of whether CD34− KSL cells 
were infected with EGFP or Cre-EGFP retrovirus, EGFP+ 
Dnmt3a2lox/2lox or Dnmt3b2lox/2lox cells were engrafted in most 
recipient mice 4 wk after transplantation. Substantial numbers 
of mice were reconstituted in myeloid, B lymphoid, and T 
lymphoid lineages with Cre-EGFP–transduced Dnmt3a2lox/2lox 
or Dnmt3b2lox/2lox cells 16 wk after transplantation. To rule 
out the possibility of Cre toxicity, long-term reconstitu-
tion of hematopoiesis by Cre-overexpressing HSCs was also 
confi  rmed in Cre-EGFP–transduced wild-type cells (Table 
S3, available at http://www.jem.org/cgi/content/full/jem
.20060750/DC1). To confi  rm that Dnmt3a- or Dnmt3b-deleted 
cells in fact contributed to long-term reconstitution, EGFP+ 
and EGFP− cells were isolated from the BM cells of the re-
cipient mice. Genomic DNA was extracted from these cells 
and was subjected to PCR-based genotyping. The 1lox and 
2lox alleles were detected in EGFP+ and EGFP− cells in Cre-
EGFP–transduced Dnmt3a2lox/2lox or Dnmt3b2lox/2lox cells, re-
spectively (Fig. 3 E). These results suggest that HSCs are able 
to undergo self-renewal and multilineage diff  erentiation in 
the absence of Dnmt3a or Dnmt3b.
We also examined BM cells in these reconstituted recipi-
ent mice. EGFP+ KSL cells were detected among BM 
cells by fl  ow cytometry (Fig. 3 F). Secondary transplantation 
of these BM cells again resulted in multilineage reconstitu-
tion by Dnmt3a- or Dnmt3b-defi   cient BM cells (Table 
S4, available at http://www.jem.org/cgi/content/full/jem
.20060750/DC1). These data reinforce the notion that in 
HSCs, the lack of either Dnmt3a or Dnmt3b does not aff  ect 
self-renewal and multilineage diff  erentiation potential.
We then went on to assess the eff  ect of the lack of both 
Dnmt3a and Dnmtb3b (Dnmt3a/Dnmt3b) on HSCs. In 
vitro methylcellulose colony assays detected no diff  erence in 
numbers, sizes, and types of colonies between Dnmt3a2lox/2lox/
Dnmt3b2lox/2lox CD34− KSL cells infected with Cre-EGFP 
retrovirus and those infected with EGFP retrovirus (Fig. 4, A 
and B). 39.9 ± 7.0% or 29.7 ± 5.2% of colonies made by 
Dnmt3a2lox/2lox/Dnmt3b2lox/2lox cells infected with EGFP or 
Cre-EGFP retrovirus exhibited EGFP fl  uorescence (Fig. 
4 C). Both genes were completely deleted from two thirds of 
EGFP+ colonies derived from Cre recombinase-transduced 
cells (Table S5, available at http://www.jem.org/cgi/
content/full/jem.20060750/DC1). Among these EGFP+ and 
gene-deleted colonies, nmEM colonies were detected (Fig. 
4 B). Transplantation of Cre-EGFP–transduced Dnmt3a2lox/2lox/
Dnmt3b2lox/2lox CD34− KSL cells showed that these cells 
were transiently able to reconstitute myeloid and B lymphoid 
lineages at 4 wk after transplantation but could not sustain 
reconstitution for 16 wk (Fig. 4 C). Most of the transient 
EGFP+ mature hematopoietic cells were Dnmt3a1lox/1lox/
Dnmt3b1lox/1lox cells (Fig. 4 D). KSL BM cells were not 
reconstituted by Cre-EGFP–transduced Dnmt3a2lox/2lox/
Dnmt3b2lox/2lox cells (Fig. 4 E). These data indicate that either 
Dnmt3a or Dnmt3b is necessary to maintain HSC self-
renewal capacity after transplantation into lethally irradi-
ated mice.
Because both Dnmt3a and Dnmt3b were expressed in 
T lymphoid cells, they were suspected to have a role in 
Figure 2.  Status of DNA methylation in hematopoietic cells. 
(A) Status of DNA methylation in hematopoietic cells was investigated by the 
detection of 5-methyl-cytosine (5-MeC). DNA methylation level was lower 
in undifferentiated cells and higher in mature hematopoietic cells, espe-
cially B and T lymphoid cells. Bars, 10 μm. (B) Status of DNA methylation 
in hematopoietic cells was confi  rmed by PCR using HpaII-digested ge-
nomic DNA. When PCR products are detectable, the genomic DNA is 
methylated low.718  ROLE OF DNMT3 IN HEMATOPOIETIC STEM CELLS | Tadokoro et al.
T lymphoid cell development. However, it is diffi   cult to eval-
uate T lymphoid lineage diff  erentiation potential in HSCs by 
competitive repopulation when HSC long-term repopulat-
ing activity is impaired. To address this issue, we transplanted 
Cre-EGFP–transduced Dnmt3a2lox/2lox/Dnmt3b2lox/2lox CD34− 
KSL cells into sublethally irradiated nonobese diabetes/
SCID mice without competitor cells (23). We then attempted 
to detect Dnmt3a/Dnmt3b-defi   cient T lymphoid cells in 
recipient mouse thymus 7 wk after transplantation. CD4+CD8− 
and CD4−CD8+ cells were indeed detected among EGFP+ cells 
Figure 3.  Deletion of Dnmt3a or Dnmt3b in HSCs. (A) A study de-
sign is schematically shown. (B) Methylcellulose colony assay was per-
formed for Dnmt3a2lox/2lox or Dnmt3b2lox/2lox CD34− KSL cells after infection 
with EGFP or Cre-EGFP retrovirus. 4% of the infected cells were cultured 
for a total of 14 d. Highly proliferative colony-forming cells, defi  ned as 
cells capable of forming colonies >1 mm in diameter, were counted. Data 
are given as mean ± SD (n = 3). (C) EGFP+ colonies were assigned colony 
types on morphological examination of colony cells. (D) Competitive re-
population was performed using Dnmt3a2lox/2lox or Dnmt3b2lox/2lox CD34− 
KSL cells after infection with EGFP or Cre-EGFP retrovirus. Transduction 
effi  ciencies were estimated by counting EGFP+ and EGFP− colonies in 
each case in B. Engraftment of Ly5.2+ donor cells was assessed by the 
ratio of the number of mice engrafted with Ly5.2+ cells to the number of 
recipient mice, and by the percentage of Ly5.2+ cells in peripheral blood 
(mean ± SD). Contribution of EGFP+ cells to all test donor-derived cells 
was assessed by the ratio of the number of mice engrafted with EGFP+ 
cells to the number of mice engrafted with Ly5.2+ cells, the percentage of 
EGFP+ cells among Ly5.2+ cells, and the percentage of EGFP+ cells among 
each lineage marker expressing Ly5.2+ cells (mean ± SD). N.D., not de-
tected. (E) Representative genotyping of BM cells reconstituted with 
Dnmt3a2lox/2lox or Dnmt3b2lox/2lox cells infected with EGFP or Cre-EGFP ret-
rovirus is shown. EGFP− or EGFP+ cells were isolated by fl  ow cytometry 
from the BM of recipient mice, and their genomic DNA was examined by 
PCR. (F) BM cells in reconstituted mice were analyzed by fl  ow cytometry. 
Only Ly5.2+ EGFP+ cells are displayed to show whether the KSL popula-
tion (red squares) is derived from transduced cells.JEM VOL. 204, April 16, 2007  719
BRIEF DEFINITIVE REPORT
(Fig. S2, available at http://www.jem.org/cgi/content/full/
jem.20060750/DC1). Collectively, HSCs without Dnmt3a 
and Dnmt3b can diff  erentiate into myeloid, B lymphoid, and 
T lymphoid lineages. Neither Dnmt3a nor Dnmt3b seems 
essential for lineage commitment processes.
We examined whether Dnmt3a and Dnmt3b control 
de novo DNA methylation activity during hematopoietic 
cell diff   erentiation. Although diff  erentiated  hematopoietic 
cells derived from Cre-EGFP–transduced wild-type CD34− 
KSL cells showed a high level of DNA methylation, that of 
diff  erentiated hematopoietic cells derived from Cre-EGFP–
transduced Dnmt3a2lox/2lox/Dnmt3b2lox/2lox CD34− KSL cells 
remained low (Fig. 5). These data indicate that Dnmt3a 
and Dnmt3b function as de novo DNA methyltransferases 
genome-wide during hematopoietic diff  erentiation. How-
ever, de novo DNA methylation does not seem necessary 
for lineage commitment processes, although it is still possi-
ble that these molecules play a role in functions of mature 
blood cells, particularly B and T lymphoid cells. Further 
work is required to identify the genes targeted by Dnmt3a 
and Dnmt3b.
This study showed that in sharp contrast to Dnmt3a/
Dnmt3b-defi  cient ES cells, which maintain replication potential, 
Dnmt3a/Dnmt3b-defi  cient HSCs progressively lose replica-
tion potential, but not diff  erentiation potential. The roles of 
de novo DNA methylation by Dnmt3a and Dnmt3b may 
diff   er between embryonic and adult stem cells from the 
developmental point of view. Alternatively, epigenetic modi-
fi  cations may diff  er substantially between in vitro–manipulated 
cell lines and cells in vivo in a physiological environment. 
Figure 4.  Deletion of both Dnmt3a and Dnmt3b in HSCs. 
(A) A methylcellulose colony assay was performed for Dnmt3a2lox/2lox/
Dnmt3b2lox/2lox CD34− KSL cells after infection with EGFP or Cre-EGFP 
retrovirus. 4% of the infected cells were cultured for a total of 14 d. 
(B) EGFP+ colonies were assigned colony types. (C) Competitive repopula-
tion was performed using Dnmt3a2lox/2lox/Dnmt3b2lox/2lox CD34− KSL cells 
after infection with EGFP or Cre-EGFP retrovirus. Transduction effi  ciencies 
were estimated by counting EGFP+ and EGFP− colonies in each case in A. 
N.D., not detected. (D) Genotyping of peripheral blood cells transiently 
reconstituted with Dnmt3a2lox/2lox/Dnmt3b2lox/2lox cells infected with EGFP 
or Cre-EGFP retro  virus is shown. EGFP− and EGFP+ cells were isolated by 
fl  ow cytometry from the peripheral blood of recipient mice, and their 
genomic DNA was examined by PCR. In the recipient mice transplanted 
with Cre-EGFP–transduced Dnmt3a2lox/2lox/Dnmt3b2lox/2lox CD34− KSL cells, 
Ly5.2+/EGFP+ peripheral blood cells were detected in 8 of 10 mice. In Cre-
EGFP–transduced Dnmt3a2lox/2lox/Dnmt3b2lox/2lox cells, Dnmt3a1lox/1lox/
Dnmt3b1lox/1lox mature cells were detected in fi  ve (red, +) of eight recipient 
mice. (E) BM cells in mice transplanted with transduced cells were ana-
lyzed by fl  ow cytometry. Only Ly5.2+ EGFP+ cells are displayed to show 
whether the KSL population (red squares) is derived from transduced cells.720  ROLE OF DNMT3 IN HEMATOPOIETIC STEM CELLS | Tadokoro et al.
ES cells should have their genomic DNA globally hyper-
methylated to maintain their diff  erentiation potential (9, 24). 
HSCs may not need such extensive genomic DNA methyla-
tion to preserve self-renewal and diff  erentiation.  Further-
more, in a recent study, it has been suggested that Dnmt3a 
and Dnmt3b localize to the replication complex, recognize 
unmethylated CpG sites, which are left untouched by Dnmt1, 
and restore methylation via de novo DNA methylation (9). 
Dnmt3a and Dnmt3b may maintain HSC-specific DNA 
methylation patterns via de novo methylation activity. To 
address this issue, we need to develop technology to analyze 
genome-wide DNA methylation status in a very limited 
number of cells. Further work is also required to address the 
mechanisms of how Dnmt3a and Dnmt3b act on the genome 
via DNA methylation to maintain self-renewal capacity in 
HSCs. Dnmt3a and Dnmt3b may take part in the regulation 
of other stem cells; indeed, realization is growing that they 
are expressed in a variety of tissue-specifi  c stem cells (25). 
There is a possibility that Dnmt3a and Dnmt3b play a role 
not only in the maintenance of self-renewal capacity in adult 
stem cells in general, but also in clonal expansion of cancer 
stem cells.
MATERIALS AND METHODS
Mice. Dnmt3a2lox/2lox, Dnmt3b2lox/2lox, and Dnmt3a2lox/2lox/Dnmt3b2lox/2lox 
mice (129SvJae × C57BL/6) have been described previously (8, 20). 
C57BL/6 mice congenic for the Ly5 locus (B6-Ly5.1) and nonobese dia-
betic/SCID mice were bred and maintained by Sankyo Labo Service, Tsu-
kuba, Japan. 2lox/2lox and C57BL/6 (B6-Ly5.1/Ly5.2) mice were 
maintained at the Animal Research Center of the Institute of Medical Sci-
ence, University of Tokyo, which is approved by the Animal Experiment 
Committee of the Institute.
Purifi  cation of HSCs. CD34− KSL cells were purifi  ed from the BM of 
Dnmt3a2lox/2lox, Dnmt3b2lox/2lox, or Dnmt3a2lox/2lox/Dnmt3b2lox/2lox mice as 
described previously in detail (15, 26). Multicolor analysis and sorting were 
performed using a MoFlo (DakoCytomation).
Transduction of CD34− KSL cells. Purifi  ed CD34− KSL cells were in-
fected with pMSCV-IRES-EGFP or pMSCV-Cre-IRES-EGFP retrovirus 
as described previously (22). Cells were preincubated with 100 ng/ml mouse 
stem cell factor (SCF) and 100 ng/ml human thrombopoietin (TPO) for 
24 h. Cells were infected with a titrated amount of retrovirus to avoid toxic-
ity by overexpression of Cre recombinase (21). After culture for an addi-
tional 2.5 d, cells were subjected to methylcellulose colony assay and 
transplantation analysis.
In vitro colony assay. Transduced CD34− KSL cells were cultured in 
a  35-mm dish containing 1 ml of 1.2% methylcellulose, 30% FCS, and 
1% BSA supplemented with 10 ng/ml mouse SCF, 10 ng/ml human TPO, 
10 ng/ml mouse IL-3, and 2 U/ml human erythropoietin. Cells were incu-
bated at 37°C in a humidifi  ed atmosphere with 5% CO2 for a total of 14 d. 
Colonies were counted under an inverted fl  uorescence microscope and in-
dividually picked from methylcellulose. Half of the cells per colony were 
stained with May-Grünwald-Giemsa solution for morphological analysis. 
The remaining cells in each colony were used as sources of genomic DNA 
for PCR genotyping.
Competitive repopulation assay. Competitive repopulation assay was 
performed by using the Ly5 congenic mouse system (26). Retrovirus-
  infected cultured cells from 2lox/2lox mice (Ly5.2) were transplanted into 
B6-Ly5.1 mice irradiated at a dose of 9.5 Gy together with 2 × 105 competi-
tor cells from a B6-Ly5.1/Ly5.2 F1 mouse. Peripheral blood cells of the re-
cipient mice were taken 4 and 16 wk after transplantation and analyzed by 
fl  ow cytometry to determine reconstitution levels in myeloid (Mac-1+/
Gr-1+), B lymphoid (B220+), and T lymphoid (CD4+/CD8+) lineages as 
described previously (27).
For secondary transplantation, recipient mice were killed between 
16 and 20 wk after transplantation, and 2 × 106 BM cells from these reci-
pients were transplanted into B6-Ly5.1 mice irradiated at a dose of 9.5 Gy. 
Peripheral blood cells of the B6-Ly5.1 recipient mice were analyzed 12 wk 
after secondary transplantation. EGFP− and EGFP+ cells separated from 
BM cell surplus to secondary-transplantation requirements were used for 
PCR genotyping.
Semiquantitative RT-PCR. cDNAs were normalized with GAPDH 
copy numbers calculated based on quantitative PCR data using TaqMan ro-
dent GAPDH control reagent (PerkinElmer; reference 28). PCR for Dnmts 
was performed using a 34-cycle program of 20 s at 94°C, 20 s at 65°C, and 
30 s at 72°C per cycle. For Dnmt1 amplifi  cation, F1 primer (5′-C  G  G  T  C  A  T-
T  C  C  A  G  A  T  G  A  T  T  C  C  T  C  -3′) and R1 primer (5′-T  G  C  T  G  T  G  G  A  T  G  T  -
A  G  G  A  A  A  G  C  T  G  -3′) were used. For Dnmt3a amplifi  cation, F4 primer 
(5′-T  C  C  C  G  G  G  G  C  C  G  A  C  T  G  C  G  A  -3′) and R1 primer (5′-T  C  C  C  C  C  A  C-
A  C  C  A  G  C  T  C  T  C  -3′) were used. For Dnmt3a2 amplifi   cation, F5 primer 
(5′-A  G  G  G  G  C  T  G  C  A  C  C  T  G  G  C  C  T  T  -3′) and R1 primer were used. For 
Dnmt3b amplifi  cation, F2052 primer (5′-G  A  A  C  A  T  G  C  G  C  C  T  G  C  A  A  G  A  -3′) 
and R2252 primer (5′-G  C  A  C  A  G  A  C  T  T  C  G  G  A  G  G  C  A  A  T  -3′) were used. 
For GAPDH amplifi  cation, F primer (5′-C  T  T  C  A  C  C  A  C  C  A  T  G  G  A  G  A  A  G-
G  C  -3′) and R primer (5′-G  G  C  A  T  G  G  A  C  T  G  T  G  G  T  C  A  T  G  A  G  -3′) were 
used. PCR for Dnmt3L was performed using a 34-cycle program of 
1 min at 94°C, 1 min at 60°C, and 1 min at 72°C per cycle. For 
Dnmt3L amplifi   cation, F primer (5′-C  G  G  C  A  C  C  A  G  C  T  G  A  A  G  G  C  C  T  T-
  C  C  A T  G  -3′) and R primer (5′-A  G  G  C  A  G  C  G  C  A T A  C  T  G  C  A  G  G  A T  C  C  G  G  -3′) 
were used (29).
Figure 5.  DNA methylation status in Dnmt3a1lox/1lox/Dnmt3b1lox/1lox 
hematopoietic cells. CD34− KSL cells of each type were cultured for 
14 d. Cre-EGFP–transduced Dnmt3a2lox/2lox/Dnmt3b2lox/2lox cells showed a 
low level of DNA methylation compared with Cre-EGFP–transduced 
wild-type cells. Bars, 20 μm.JEM VOL. 204, April 16, 2007  721
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Immunocytostaining for Dnmt3a, Dnmt3b, and 5-MeC. Cells were 
directly sorted by fl  ow cytometry into a droplet of medium on a poly-
l-lysine–coated glass slide. After fi  xation with 2% paraformaldehyde, cells 
were incubated for 12 h at 4°C with anti-Dnmt3a antibody (clone 64B1446; 
IMGENEX) at a dilution of 1:400 and anti-Dnmt3b antibody (Abcam) at a 
dilution of 1:200. After washes, cells were reacted for 30 min at room 
temperature with Alexa Fluor 488–labeled goat anti–rabbit IgG or Alexa 
Fluor 647–labeled goat anti–mouse IgG secondary antibody (Invitrogen) at 
a dilution of 1:500. Immunocytochemistry with anti–5-MeC antibody (su-
pernatant from hybridoma cultures) was performed as described previously 
(16, 30). In this protocol, each cell was cytospun onto slide glasses. An anti–
5-MeC antibody was detected by an Alexa Fluor 647–labeled goat anti–
mouse IgG secondary antibody (Invitrogen) at a dilution of 1:500. A Leica 
TCS SP2 AOBS confocal microscope (Leica Microscopy System) was used 
to visualize fl  uorescent signals.
Detection of DNA methylation status from PCR products. DNA of 
each hematopoietic cell (103 cells per sample) was digested with HpaII or 
MspI overnight. After their digestion products were purifi  ed, they were li-
gated to RHpa adaptor (17). 0.1 vol of the ligation products was amplifi  ed 
with RHpa24 primer (5′-A  G  C  A  C  T  C  T  C  C  A  G  C  C  T  C  T  C  A  C  C  G  A  C  -3′) 
using a 25-cycle program of 1 min at 95°C and 3 min at 72°C per cycle. 
DNA methylation status of each cell was checked by electrophoresing their 
PCR products in 1% agarose gel.
Online supplemental material. Fig. S1 shows detection of deleted alleles 
in blood colonies. Fig. S2 shows detection of Dnmt3a1lox/1lox/Dnmt3b1lox/1lox 
T lymphoid cells. Table S1 shows detection of deleted alleles in blood colo-
nies formed by Dnmt3a2lox/2lox cells infected with Cre-EGFP retrovirus. 
  Table S2 shows detection of deleted alleles in blood colonies formed by 
Dnmt3b2lox/2lox cells infected with Cre-EGFP retrovirus. Table S3 shows 
effi   ciency of competitive repopulation in Cre-EGFP–transduced wild-type 
CD34− KSL cells. Table S4 shows secondary transplantation of Cre-EGFP–
transduced Dnmt3a2lox/2lox or Dnmt3b2lox/2lox BM cells. Table S5 shows detec-
tion of deleted alleles in blood colonies formed by Dnmt3a2lox/2lox/
Dnmt3b2lox/2lox cells infected with Cre-EGFP retrovirus. The online 
supplemental material is available at http://www.jem.org/cgi/content/
full/jem.20060750/DC1.
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